Siemens Healthcare Diagnostics, Inc. recalls ADVIA Centaur aTPO Assay
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Positive bias in patient results at and below the cut-off of 60 U/mL with the lots listed in the table below when compared to alternate lots on the Atellica IM analyzer.
- Products
-
- ADVIA Centaur aTPO Assay
- Where it was sold
-
Worldwide distribution - US Nationwide.
Nationwide
- Units affected
- 5622 kits
- About this recall
- ADVIA Centaur aTPO Assay, Material Number 10630886 (100 Test) and 10630887 (500 Test)